Harm J Bogaard Selected Research

Protandim

5/2013	Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension?
11/2009	Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harm J Bogaard Research Topics

Disease

13	Pulmonary Arterial Hypertension 10/2021 - 05/2012
13	Pulmonary Hypertension 01/2021 - 01/2008
13	Hypoxia (Hypoxemia) 01/2019 - 01/2002
8	Hypertrophy 01/2019 - 11/2009
6	Fibrosis (Cirrhosis) 01/2019 - 11/2009
5	Heart Failure 01/2021 - 05/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 11/2012 - 01/2008
3	Neoplasms (Cancer) 01/2021 - 05/2012
3	Vascular Remodeling 01/2016 - 02/2012
2	Familial Primary Pulmonary Hypertension 10/2021 - 09/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2013 - 01/2013
2	Right Ventricular Dysfunction 01/2013 - 05/2011
2	Emphysema 01/2013 - 01/2012
2	Microvascular Rarefaction 05/2011 - 09/2010
1	Vascular Diseases (Vascular Disease) 11/2021
1	Hyperventilation 10/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Cytopenia 01/2021
1	COVID-19 01/2021
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Channelopathies 10/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2017
1	Right Ventricular Hypertrophy 11/2017
1	Iron Deficiencies 09/2015
1	Cardiomegaly (Heart Hypertrophy) 06/2013
1	Pulmonary Emphysema 01/2013

Drug/Important Bio-Agent (IBA)

6	Semaxinib (SU5416)IBA 01/2019 - 09/2010
5	Oxygen (Dioxygen)IBA 01/2021 - 01/2002
4	Proteins (Proteins, Gene)FDA Link 06/2013 - 11/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 11/2009
3	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2014 - 09/2010
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2013 - 09/2010
2	Bisoprolol (Concor)FDA LinkGeneric 10/2021 - 11/2014
2	MonocrotalineIBA 01/2018 - 02/2012
2	Messenger RNA (mRNA)IBA 02/2015 - 11/2009
2	Carvedilol (Coreg)FDA LinkGeneric 06/2013 - 09/2010
2	ProtandimIBA 05/2013 - 11/2009
2	Heme Oxygenase-1IBA 05/2013 - 11/2009
2	GoldIBA 11/2012 - 01/2008
2	CopperIBA 05/2012 - 01/2012
1	alovudineIBA 07/2021
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 07/2021
1	Imatinib Mesylate (Gleevec)FDA Link 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Collagen Type III (Type III Collagen)IBA 01/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2019
1	nintedanibIBA 01/2019
1	Platelet-Derived Growth FactorIBA 01/2019
1	HLA-DPA1 antigen (HLA DPA1)IBA 01/2019
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2019
1	PotassiumIBA 10/2018
1	p38 Mitogen-Activated Protein KinasesIBA 11/2017
1	PH 797804IBA 11/2017
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 01/2016
1	CaspasesIBA 01/2016
1	IronIBA 09/2015
1	Pharmaceutical PreparationsIBA 06/2015
1	ProcollagenIBA 02/2015
1	Iloprost (Ventavis)FDA Link 02/2015
1	CollagenIBA 02/2015
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 02/2015
1	Connective Tissue Growth FactorIBA 02/2015
1	Angiotensin Receptor AntagonistsIBA 11/2014
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2014
1	Losartan (Cozaar)FDA LinkGeneric 11/2014
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2014
1	CXC ChemokinesIBA 01/2014
1	Phenobarbital (Luminal)FDA Link 01/2014
1	von Willebrand FactorIBA 01/2014
1	LigandsIBA 01/2014
1	plerixafor FDA Link 01/2014
1	CXCR ReceptorsIBA 01/2014
1	Dasatinib (BMS 354825)FDA Link 09/2013
1	Oxidants (Oxidizing Agents)IBA 05/2013
1	3-nitrotyrosineIBA 05/2013
1	EnzymesIBA 05/2013
1	NitrogenIBA 05/2013
1	AntioxidantsIBA 05/2013
1	Valproic Acid (Depakote)FDA LinkGeneric 04/2013
1	Vorinostat FDA Link 04/2013
1	Histones (Histone)IBA 04/2013
1	CeramidesIBA 01/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013
1	SphingolipidsIBA 01/2013
1	FenretinideIBA 01/2013
1	sphingosine kinaseIBA 01/2013
1	SphingosineIBA 01/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2013
1	Estrogens (Estrogen)FDA Link 01/2013
1	Adenosine Diphosphate (ADP)IBA 01/2013
1	MicroRNAs (MicroRNA)IBA 09/2012
1	tetrathiomolybdate (ammonium tetrathiomolybdate)IBA 05/2012

Therapy/Procedure

7	Therapeutics 11/2021 - 06/2013
2	Endarterectomy (Thromboendarterectomy) 11/2021 - 01/2017
1	Lung Transplantation 10/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Subcutaneous Injections 01/2019